<?xml version="1.0" encoding="UTF-8"?>
<p>A total of 408 newly diagnosed with HIV/AIDS patients were assessed. 
 <xref rid="pone.0214800.t001" ref-type="table">Table 1</xref> and 
 <xref rid="pone.0214800.t002" ref-type="table">Table 2</xref> summarize the basic characteristics of the study population. 
 <xref ref-type="fig" rid="pone.0214800.g001">Fig 1</xref> depicts the mean and standard deviation of CD3
 <sup>+</sup>, CD3
 <sup>+</sup>CD4
 <sup>+</sup>, CD3
 <sup>+</sup>CD8
 <sup>+</sup>, CD45
 <sup>+</sup>, CD3
 <sup>+</sup>/CD45
 <sup>+</sup>,CD3
 <sup>+</sup>CD4
 <sup>+</sup>/CD45
 <sup>+</sup>, CD3
 <sup>+</sup>CD8
 <sup>+</sup>/CD45
 <sup>+</sup>, and CD3
 <sup>+</sup>CD4
 <sup>+</sup>CD8
 <sup>+</sup>/CD45
 <sup>+</sup> in two box plots. The HIV patients were grouped according to age (1) 30–59 years, (2) ≤ 29 years, and (3) ≥ 60 years. The study sample was primarily male (65%, n = 267), 11.8% were ethnic minorities, and the mean CD4 T cell count was 224 cells/μL across all individuals.
</p>
